Alnylam Pharmaceuticals, Inc.
2021 Q4 - 2025 Q4 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/15/2026 | 111,510 | 0.2% | 278,657 | 12/31/2025 |
| 2025 Q3 | 10/20/2025 | 143,172 | 0.2% | 310,804 | 9/30/2025 |
| 2025 Q2 | 7/25/2025 | 100,552 | 0.2% | 312,216 | 6/30/2025 |
| 2025 Q1 | 4/24/2025 | 69,292 | 0.1% | 270,924 | 3/31/2025 |
| 2024 Q3 | 10/18/2024 | 116 | 0.0% | 420 | 9/30/2024 |
| 2024 Q2 | 7/26/2024 | 63 | 0.0% | 259 | 6/30/2024 |
| 2024 Q1 | 4/29/2024 | 25 | 0.0% | 168 | 3/31/2024 |
| 2023 Q4 | 1/25/2024 | 5 | 0.0% | 25 | 12/31/2023 |
| 2023 Q3 | 10/27/2023 | 13,816 | 0.0% | 78,013 | 9/30/2023 |
| 2023 Q2 | 7/18/2023 | 5,297 | 0.0% | 27,889 | 6/30/2023 |
| 2023 Q1 | 4/13/2023 | 6,887 | 0.0% | 34,381 | 3/31/2023 |
| 2022 Q4 | 1/23/2023 | 8,857 | 0.0% | 37,268 | 12/31/2022 |
| 2022 Q3 | 10/26/2022 | 7,508 | 0.0% | 37,514 | 9/30/2022 |
| 2022 Q2 | 7/25/2022 | 5,704 | 0.0% | 39,117 | 6/30/2022 |
| 2022 Q1 | 5/2/2022 | 6,525 | 0.0% | 39,968 | 3/31/2022 |
| 2021 Q4 | 1/28/2022 | 4,382 | 0.0% | 25,847 | 12/31/2021 |